GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria

Clinical trial NCT06971900 · COMPLETED

Trial details

NCT number: NCT06971900
Sponsor: Portal Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Erythropoietic Protoporphyria (EPP)

Start date: 2025-04-04
Primary completion: 2025-11-22
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.